Evaluation of adipocytokines and traditional cardiometabolic risk factors in young male cancer survivors: an age‐matched control study

Life expectancy of cancer survivors has doubled in the past four decades; however, death due to cardiovascular disease is more prevalent in survivors than the general population.

[1]  J. Bourhis,et al.  Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure. , 2015, Radiation protection dosimetry.

[2]  M. Rutter,et al.  Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men. , 2015, The Journal of clinical endocrinology and metabolism.

[3]  M. Stevens,et al.  Reduced beta‐cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation , 2015, Clinical endocrinology.

[4]  E. Riboli,et al.  Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival , 2014, Journal of the National Cancer Institute.

[5]  J. Olsen,et al.  Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943-2009. , 2014, Journal of the National Cancer Institute.

[6]  N. Brunetti,et al.  Cardiovascular sequelae of radiation therapy , 2014, Clinical Research in Cardiology.

[7]  M. Kubota,et al.  Adipocytokines in childhood cancer survivors and correlation with metabolic syndrome components , 2013, Pediatrics international : official journal of the Japan Pediatric Society.

[8]  R. Pieters,et al.  Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia. , 2013, Leukemia research.

[9]  E. Picano,et al.  Telomere shortening and ionizing radiation: A possible role in vascular dysfunction? , 2012, International journal of radiation biology.

[10]  H. Seo,et al.  Metabolic syndrome in adult cancer survivors: a meta-analysis. , 2012, Diabetes research and clinical practice.

[11]  G. Armstrong,et al.  Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  O. Garrone,et al.  Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. , 2011, International journal of cardiology.

[13]  A. Gratwohl,et al.  Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor , 2011, Haematologica.

[14]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[15]  S. Lipsitz,et al.  Characteristics and Determinants of Adiposity in Pediatric Cancer Survivors , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[16]  F. Roila,et al.  Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  H. Caron,et al.  Hypertension in long-term survivors of childhood cancer: a nested case-control study. , 2010, European journal of cancer.

[18]  N. Keating,et al.  Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. , 2010, Journal of the National Cancer Institute.

[19]  K. Ness,et al.  Cardiovascular Risk Factors in Adult Survivors of Pediatric Cancer—A Report from the Childhood Cancer Survivor Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[20]  L. Robison,et al.  Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. , 2009, Archives of internal medicine.

[21]  A. Giobbie-Hurder,et al.  Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors , 2009, Cancer Causes & Control.

[22]  G. Guerra‐Júnior,et al.  Adiposity in childhood cancer survivors: insights into obesity physiopathology. , 2009, Arquivos brasileiros de endocrinologia e metabologia.

[23]  P. Scherer,et al.  Adiponectin, Cardiovascular Function, and Hypertension , 2008, Hypertension.

[24]  A. Petrilli,et al.  Leptin Assessment in Acute Lymphocytic Leukemia Survivors: Role of Cranial Radiotherapy? , 2007, Journal of pediatric hematology/oncology.

[25]  R. Eastell,et al.  Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. , 2007, The Journal of clinical endocrinology and metabolism.

[26]  P. Whincup,et al.  Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. , 2007, Atherosclerosis.

[27]  K. Steinbeck,et al.  Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. , 2006, The Journal of clinical endocrinology and metabolism.

[28]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[29]  R. Baumgartner,et al.  Relationship of Obesity and Physical Activity with C-Peptide, Leptin, and Insulin-Like Growth Factors in Breast Cancer Survivors , 2005, Cancer Epidemiology Biomarkers & Prevention.

[30]  T. Wilsgaard,et al.  Blood pressure and body mass index in long-term survivors of testicular cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[32]  C. Hudis,et al.  Cardiac dysfunction in the trastuzumab clinical trials experience. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[34]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[35]  R. Baumgartner,et al.  Associations of insulin resistance and adiponectin with mortality in women with breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  R. Gottlieb,et al.  Chemotherapy and cardiotoxicity. , 2008, Reviews in cardiovascular medicine.

[37]  Y. Matsuzawa.  Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.

[38]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[39]  J. Snowden,et al.  Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide , 2000, Bone Marrow Transplantation.